Poll: What does the future look like for single cell genomics?

With Fluidigm stepping aside and a slew of competitors looking to stake their claim, the world of single cell genomics…

Tempus generates chatter at #ASCO2017

Chicago, IL – Many exciting announcements have been made at ASCO this year, with our favorite picks highlighted here. One…

ASCO Musings: Diagnostics and Research Tools Takeaways from ASCO17

Chicago, IL June 6, 2017 – My colleague and I spent a few days wandering around the exhibit hall at…

Competitors Jostle for Share as Fluidigm Signals Deprioritization of Single-Cell Genomics

Los Angeles, CA May 31, 2017 – In Fluidigm’s Q1 2017 earnings call, Chris Linthwaite signaled the company’s deprioritization of…

Talking Healthcare Analytics with Wout Brusselaers, CEO of Deep 6 AI

I recently had the pleasure to sit down with Wout Brusselaers, founder and CEO of South by Southwest Accelerator Pitch…

AGBT 2017: DeciBio Highlights

Hollywood, FL February 17, 2017 – We attended AGBT 2017, and had a chance to talk with multiple vendors and…

NanoString poised to make a play in clinical sequencing with Hyb & Seq

Hollywood, FL – Exciting times are upon us again at AGBT with multiple announcements from life science research tools players.…

Illumina, Bio-Rad, and 10X Genomics look to take advantage of the market that Fluidigm built

Santa Monica, CA – A year after announcing their partnership, Bio-Rad and Illumina launched their Single-Cell Sequencing Solution at the…

Diagnostic Biomarkers for Cancer Immunotherapy – Updated Jan. 2017

We continue to track the immuno-oncology (I/O) space closely and have recently made some updates to our prior analysis (here:…

Clinical Diagnostics Testing Paradigm: A Market in Transition

Santa Monica, CA – The healthcare testing landscape is constantly evolving to provide quality care and meet the changing needs…

How can we help?

Avoid blind spots in your market. Get the insights you need to accelerate innovation.

Contact Us